Rossari Biotech (ROSSARI.NS) Stock Price

Rossari Biotech Price

NSE·CLOSED
441.00
​
Market closed

Revenue has compounded at 29.7% per year over the past 10 years to 23.96 B INR. Earnings per share have grown at 44.6% per year over the last 10 years. Rossari Biotech's net margin stands at 6.2%, broadly stable from 6.6% several years earlier. Rossari Biotech currently offers a dividend yield of about 0.11%. The payout ratio is around 2% of earnings. Analysts set a median price target of 646.17 INR, implying 46.5% above the current price. Of 11 analysts, 9 rate the stock a buy — an overall Buy consensus.

Rossari Biotech stock price

Access this data via the Eulerpool API

Rossari Biotech business model & stock analysis

Rossari Biotech Ltd. operates as a specialty chemicals manufacturing company. The company is headquartered in Mumbai, Maharashtra and currently employs 500 full-time employees. The company went IPO on 2020-07-23. The firm is engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. The company operates through three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). HPPC produces acrylic polymers, manufacturing a sustainable range of products for various applications in the cleaning industry. TSC is focused on providing customers with eco-friendly, sustainable chemical solutions. The company provides solutions for pre-treatment, dyeing and printing, finishing, and specialty chemicals for the entire value chain of the textile industry. AHN provides wellness solutions for pet animals and poultry, focusing on their health and performance.

Frequently asked questions about Rossari Biotech

Analysts currently set an average price target of 648.21 INR for the Rossari Biotech stock (median: 646.17 INR), implying +51.6 % versus the latest price. The consensus is based on 11 analyst ratings.

11 analysts currently rate the Rossari Biotech stock: 9 recommend buying, 2 holding and 0 selling.

Converted at the current exchange rate, the Rossari Biotech share trades at 4.05 EUR (441.00 INR).

The Rossari Biotech share (ROSSARI.NS) is listed on 2 stock exchanges, including: NSE (Indien) (ROSSARI.NS).

The revenue of Rossari Biotech is 23.96 B INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Rossari Biotech is 1.49 B INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Rossari Biotech is currently 16.39. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Rossari Biotech stock.

The price-to-sales ratio (P/S) of Rossari Biotech is currently 1.02. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Rossari Biotech stock.

The Eulerpool Quality Score for Rossari Biotech is 6/10.

The ISIN of Rossari Biotech is INE02A801020. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Rossari Biotech is ROSSARI.NS. The ticker symbol is used to trade Rossari Biotech shares on the stock exchange.

Fair ValueTerminal
388.08 INR
Over-/UndervaluationTerminal
Fairly valued
Industry
Chemicals
Number of shares
Employees
Revenue per Employee
47.93 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website rossari.com
Country
Currency
INR
Initial public offering
Jul 23, 2020
ISIN
INE02A801020
Cusip
Y7S25N116
Market capitalization
24.42 B INRLarge Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee 2027
15.64
P/Ee 2028
13.14
P/S
P/Se
0.91
EV/EBIT
13.47
P/B Ratio
1.83
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
8.43 %
Gross Margin
20.60 %
EBIT Margin
8.63 %
Net Margin
6.23 %
EPS (Earnings Per Share)
26.91 INR
Net Debt / EBIT
1.66
Debt/Equity
0.33
Dividend
Dividend yield
0.11 %
Est. Dividend Yield
0.11 %
Payout Ratio
2.25 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
5 years
Dividend not reduced since
5 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Sep 30, 2026, 4:04 PM

Rossari Biotech Peer Group

Rossari Biotech Ticker

BSE · ROSSARI.BONSE INDIA · ROSSARI.NS

Rossari Biotech FIGI

ROSSARI:IN · BBG00BM6V5N6ROSSARI:IB · BBG00SC9JVB4ROSSARI:IS · BBG00SC9JVD2

All fundamentals and in-depth analysis of Rossari Biotech

Our stock analysis for Rossari Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rossari Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.